Social media listening has become a vital tool for pharmaceutical brands to learn rapidly about their customers’ needs and experiences. But in the regulated pharmaceutical industry, the idea of searching through unlimited public conversations can be daunting and can raise challenging questions from pharmacovigilance and medical compliance colleagues.

If you have ever wondered how to run a social media listening study that your compliance colleagues will approve of, or if you are a pharmacovigilance professional and want to understand the risks and opportunities in social listening, then this webinar is for you.

In this Webinar, you will discover:

The risks to your pharmacovigilance teams when you conduct social media listening, and how can you mitigate those risks
Tried and tested principles for ensuring compliance with industry regulations and standards for compliant market research and social media listening, including those set by BHBIA and ABPI
How to build compliance into your social media listening from the start
Examples of pharmacovigilance in HCP social media listening

The webinar will focus on social media listening of healthcare professionals’ online conversations, with principles that can also be applied to public and patient listening. Request online now

Fill out your details below to register for this event:

About CREATION

CREATION.co has been planning, implementing, and reporting on social media listening for pharmaceutical brands for more than ten years and has been at the forefront of digital compliance planning, working with industry to support the development of social media guidelines.

The company is frequently represented among international speakers at industry compliance and medical information groups including PIPA (Pharmaceutical Industry Pharmacovigilance Association), BHBIA (British Healthcare Business Intelligence Agency), and DIA (Drug Information Association).

On-demand Webinar: Pharmacovigilance in HCP Social Media Listening

Related Resources

Product Launch Tracker: HCPs are enthusiastic about the approval of two nasal sprays and an antifungal treatment.

Respiratory tracker: eHCPs respiratory conversation peaked on World Asthma Day and at ESPID2023

How HCPs discuss rare disease online

The line crossers: drugs discussed and prescribed by multiple physician specialties

Reflections on Reuters Pharma Europe 2023

eHCPs divided on new guidelines and challenges facing paediatric obesity

Related Case Studies

Related Solutions